Every day researchers work towards finding new breakthroughs in cancer. Clinical trials play a pivotal role in bringing that defeat closer.
Clinical trials test promising new treatments on people to see if they are better than existing cancer treatments. The trial process is long starting many years before an actual treatment can be used.
By joining a clinical trial you are helping to create new breakthroughs in cancer research. Hundreds of thousands of people all over the world have taken part in clinical trials that have lead to safer and more effective treatments for many cancers.
It is important to note that not all cancer patients are eligible to take part in clinical trials and there are not clinical trials for all types of cancer.
You may decide to join a clinical trial because:
- The treatment you receive will be at least the best available for your illness.
- Your health may improve because of the treatment you receive.
- You may receive a treatment you would not otherwise have access to.
- Your health will be carefully checked by the treatment team running the trial.
- You will be part of the worldwide effort to improve cancer treatment.
For more information on clinical trials please click here.
If you would like information regarding any of the below clinical trials, please contact the appropriate Clinical trials manager:
Ashford Cancer Centre: Helen Daykin, +61 8 8292 2240
Flinders Medical Centre: Alex Scott-Hoy, +61 8 8204 4830
The Queen Elizabeth: Sue Yeend, +61 8 8222 6148
Lyell McEwin Hospitals: Julie Rowe or Rohit Joshi +61 8 8282 0833
Royal Adelaide Hospital: Anne Milton, +61 8 7074 2342
Current clinical trials for all cancers cancer
|Not Yet Recruiting||BGB290 Phase I Solid Tumour: A Phase IA/IB, Open Label, Multiple Dose, Dose Escalation and Expansion Study to Investigate the Safety, Pharmacokinetics, Food Effect, and Antitumor Activities of BGB-290 in Subjects with Advanced Solid Tumors||Flinders Medical Centre|
|Recruiting||BPIT Blood Predictors in Treatment||Flinders Medical Centre|
|Not Yet Recruiting||D6020C00001- Phase 1/2, open label study to evaluate the safety and antitumor activity of MED10680 (AMP-514) in combination with MED14736 and MED 10680 monotherapy in subjects with select advanced malignancies||Royal Adelaide Hospital|
|Recruiting||PERT1 A prospective cohort study of patients with Cancer of Unknown Primary (CUP) to create a national information resource and improve the understanding of the molecular biology, clinical, quality of life and psychosocial characteristics||Flinders Medical Centre|
|Recruiting||RAS cfDNA Evaluation of temporal dynamics of RAS Mutation Emergence in Cell Free DNA (cfDNA) in response to first-line cetuximab anti-EGFR therapy in Patients with Metastatic||Flinders Medical Centre|
|Not yet recruiting||Stop Cancer Pain Implementing clinical practice guidelines for cancer pain in adults to ensure equitable, cost-effective, evidence-based, person-centred care: A phase III pragmatic stepped wedge cluster randomised controlled trial of guidelines and screening with implementation strategies versus guidelines and screening alone to improve pain in adults with cancer attending outpatients oncology and palliative care centres||Flinders Medical Centre|
|Not yet recruiting||SUPER2 Understanding the Experience of Advanced Cancer for Known and Unknown Primaries||Flinders Medical Centre|